Frontal Fibrosing Alopecia and Cosmetic Surgery: Why a Receding Hairline and Vanishing Eyebrows After Fifty Can Be Scarring Hair Loss, Why Transplants and Hairline Lowering Often Disappoint, What It Means for Facelift and Brow Lift Incisions, and Which Camouflage Holds Up

The consultation usually begins with a photograph. A patient holds up a picture from ten or fifteen years ago, points at her forehead, and says the hairline has moved. She has tried biotin, a new shampoo, and a minoxidil foam from the pharmacy. The temples are thinner, there are a few long, lonely hairs standing alone in skin that used to be covered, and the outer thirds of her eyebrows are gone. She would like to know whether a hair transplant, a hairline lowering, or a brow lift would put things back where they were.

For many women in this situation the answer begins somewhere other than the operating room. A receding frontal hairline in a postmenopausal woman, especially with eyebrow loss, is the classic presentation of frontal fibrosing alopecia, usually shortened to FFA. It is not the ordinary thinning that comes with age or hormones. It is an inflammatory, scarring condition in which the immune system attacks hair follicles and replaces them with fibrous tissue, so the hair it takes does not come back. It can stabilize on its own, it can be slowed with treatment, and it can keep creeping backward for years. Any cosmetic procedure near the hairline or brows that ignores it is built on moving ground.

This piece explains what FFA is and how to tell it from other kinds of hair loss, why diagnosis and a period of stability come before cosmetic surgery, what the condition does to hair transplants, hairline lowering, and eyebrow restoration, how it changes the planning of facelift, brow lift, and forehead procedures, and which kinds of camouflage tend to work. As with any general article, it does not replace an examination: the diagnosis is made by looking closely at the scalp, often with a magnifying dermatoscope and sometimes with a biopsy.

What frontal fibrosing alopecia is, and why it is not ordinary thinning

The short answer: frontal fibrosing alopecia is a form of scarring hair loss, generally classified as a variant of lichen planopilaris, that destroys follicles along the front and sides of the hairline and often the eyebrows, most commonly in postmenopausal women, and because the follicles are replaced by scar the lost hair does not regrow.

The condition was first described in 1994 by the Australian dermatologist Steven Kossard in a small group of postmenopausal women with a band of hair loss along the front of the scalp. For years it was considered rare. Over the past decade and a half, dermatology journals have reported a striking increase in cases worldwide, and specialist hair clinics now see it routinely. Most patients are women after menopause, but it also occurs in younger women and in men, and it has been described across skin tones and ethnic backgrounds.

The hair loss in FFA has a recognizable pattern, and patients often notice the pieces before they notice the whole:

• A receding band at the front and temples. The hairline moves back evenly, sometimes a centimeter or more, and the temples and the hair in front of the ears thin out. Sideburns in women often disappear.
• A pale, smooth strip of skin. The newly bare skin is often paler and shinier than the sun-exposed forehead below it, because it spent decades under hair. That color contrast is one of the most useful clues.
• Lonely hairs. Isolated long hairs remain standing in the bare zone, survivors of the original hairline.
• Redness and scale at the edge. Around the follicles at the advancing margin there may be a little redness and fine scale, signs of active inflammation.
• Eyebrow loss. Partial or complete loss of the eyebrows is common and often comes before the scalp changes. Eyelashes, body hair, and the fine hair on the face can also be affected.
• Facial papules. Small, skin-colored bumps on the temples and cheeks, caused by inflammation around the fine facial hairs, show up in a subset of patients.

None of that looks quite like the pattern hair loss that most transplant surgeons see every day. Female pattern hair loss usually widens the part and thins the crown while keeping the frontal hairline; male pattern loss recedes at the temples and crown but leaves healthy-looking follicles that can be relocated. Telogen effluvium, the diffuse shedding that can follow surgery, illness, or stress and is described in the piece on hair shedding after surgery, thins everything evenly and grows back. Alopecia areata makes round, smooth patches without scarring. FFA differs from all of these because the follicle itself is destroyed. When dermatologists look with a dermatoscope at the bare band, they see skin without follicular openings, which is the visual definition of scarring.

The cause is not settled. FFA is generally regarded as an immune-mediated disease, and a large genetic study published in 2019 identified several gene regions linked to susceptibility, including one in the immune-system HLA region, which supports the idea that some people are predisposed. Hormones seem to play a role, given how strongly the condition clusters after menopause. And a series of case-control studies has reported an association between FFA and regular use of leave-on facial products, including sunscreens and moisturizers containing sunscreen. That association has been widely publicized, but an association is not proof of cause, and dermatology groups have not concluded that sunscreen causes FFA. Patients who stop sun protection out of fear trade a possible risk for a well-established one, as the piece on lasers for sun spots and pigmentation explains about sun damage. A reasonable middle ground is to discuss the question with the dermatologist rather than abandon sun protection on one's own.

FFA can also appear alongside other conditions. It sometimes coexists with lichen planus elsewhere on the body or with lichen planus pigmentosus, a form that leaves gray-brown patches on the face and neck, more often in darker skin. It has been reported alongside thyroid disease and other autoimmune conditions, and anyone with an autoimmune history should read the piece on cosmetic surgery with autoimmune disease for the broader planning issues.

Diagnosis, treatment, and what "stable" means before anyone operates

The short answer: FFA is diagnosed by a dermatologist with a scalp examination, dermoscopy, and often a biopsy from the active edge; treatment aims to stop progression rather than regrow hair, and most surgeons and hair specialists want the disease to be quiet for a sustained period before any procedure near the hairline or brows.

A patient whose hairline has moved should see a dermatologist, ideally one with a particular interest in hair disorders, before seeing a surgeon. The American Academy of Dermatology's patient materials describe FFA as one of the scarring alopecias and stress that early diagnosis matters, because treatment can preserve hair that has not yet been lost but cannot restore hair that has.

The workup usually includes a careful history (when the change began, eyebrow and body hair, menopause and hormone use, products used on the face, other skin conditions), photographs of the hairline from fixed angles, and dermoscopy. When the picture is not clear, a small punch biopsy from the inflamed margin, rather than from the already bare skin, confirms the diagnosis and separates FFA from other scarring alopecias, from discoid lupus, and from pattern loss. Blood tests may look for thyroid disease or other contributors. Patients sometimes measure the distance from the eyebrows to the hairline at each visit, which turns a vague impression into a number.

Treatment is aimed at calming the inflammation. Commonly used options include:

• Corticosteroids applied to the skin or injected. Strong topical steroids and steroid injections into the active margin and sometimes the eyebrows are a mainstay.
• Topical calcineurin inhibitors. Tacrolimus or pimecrolimus can be used on the margin and on facial skin, where long-term steroid use thins the skin.
• 5-alpha-reductase inhibitors. Finasteride and dutasteride, prescribed off label, appear in several case series to help stabilize the disease in some women. These drugs can cause birth defects in a male fetus, so women who could become pregnant need reliable contraception and a frank discussion.
• Oral anti-inflammatory and immune-modulating drugs. Hydroxychloroquine, doxycycline, and pioglitazone have all been used, and newer drugs, including the JAK inhibitors, have been reported in small series. Low-dose oral minoxidil is sometimes added to thicken remaining hair.

There is no drug approved by the FDA specifically for FFA, and most of the evidence comes from case series and expert experience rather than large randomized trials. That uncertainty is important for anyone planning cosmetic work, because the question a surgeon needs answered is not whether the patient is on treatment but whether the disease is actually quiet.

"Stable" in this context means no measurable movement of the hairline, no redness or scale at the margin, and no further eyebrow loss over a sustained period, documented with photographs and measurements rather than memory. Hair specialists commonly talk about one to two years of stability before considering a transplant, and some ask for longer. Even then, stability is a judgment, not a guarantee. FFA can flare after years of quiet, and some patients appear stable only because the medication is suppressing activity that would return if it stopped.

This also explains why a patient who has been told her hair loss is "just aging" by a cosmetic practice may want a second opinion. The piece on getting a second consultation explains how to ask for one without starting from scratch. A surgeon who glances at a receding hairline in a woman of sixty and offers a transplant date without asking about the eyebrows, the margin, or a dermatology diagnosis has skipped the step that determines whether the operation can work.

"

A hair transplant moves follicles. It does not change the disease that destroyed the ones that were there, and in frontal fibrosing alopecia that disease can find the new ones too.

"

Hair transplants, hairline lowering, and eyebrow restoration in a scarring disease

The short answer: hair transplants in FFA often look good in the first year and then lose grafts over the following years as the disease reaches them, hairline lowering is generally considered a poor choice because it advances skin that may lose its hair and relies on a hairline that may keep moving, and eyebrow transplants carry the same risk, which is why many specialists steer patients toward camouflage first.

Hair transplantation. The appeal is obvious: move healthy follicles from the back of the scalp into the bare band. The procedure is described in general in the piece on what actually works in hair transplants. In FFA, published case series tell a cautionary story. Many patients see reasonable growth at six to twelve months, and then the transplanted hair thins over the next two to five years as the inflammation spreads into the new grafts. Results are better when the disease has been stable for a long time and remains on treatment, but even in those groups graft loss over time is common. The donor area at the back of the scalp is a finite supply, and scarring alopecia in the recipient zone wastes it. There is also a smaller concern that surgical trauma can activate quiet disease in some patients, similar to the way lichen planus can appear in a scar, a pattern known as the Koebner phenomenon, which is explained in the piece on vitiligo, scars, and the Koebner effect.

A patient who wants to proceed despite that history needs a realistic plan: documented stability, ongoing treatment before and after, a conservative test session or limited number of grafts rather than a full hairline, low density with an expectation of some loss, and a frank discussion about what happens if the disease returns. The International Society of Hair Restoration Surgery has addressed scarring alopecias in its educational material, and a surgeon who works with the patient's dermatologist rather than around them is a better sign than one who promises permanence.

Hairline lowering and forehead reduction. The operation described in the piece on hairline lowering and forehead reduction removes a strip of forehead skin and advances the hair-bearing scalp forward. It works for people with a naturally tall forehead and a stable, dense hairline. FFA undermines both conditions. The hair just behind the hairline is the very hair FFA attacks next, so the advanced scalp may lose its hair and expose the incision. The scar sits along a hairline that may keep receding, leaving a visible line in the middle of the forehead. And the tension of advancing the scalp is generally considered unwise in skin that is already inflamed and scarring. Most surgeons who perform the operation regard active or recent FFA as a contraindication, and patients who have been offered it without a scalp examination should take that seriously.

Eyebrow transplants. As the piece on eyebrow and beard transplants notes, transplanted brows in FFA can look successful at a year and then fail over the following years as the disease takes the new follicles. The eyebrows are also involved in a large share of patients, often first, so the transplanted area is exactly where activity is most likely. For many patients, cosmetic tattooing and makeup do more for the brows with less to lose, as discussed below.

Laser and light devices. Low-level light therapy caps and combs have been marketed for hair loss in general. Their evidence in pattern hair loss is modest, and their evidence in scarring alopecia is thin; they will not revive follicles that have been replaced by scar. Patients sometimes buy them while delaying a diagnosis, which is the real cost.

Facelift, brow lift, and forehead procedures when the hairline is moving

The short answer: FFA matters even when the procedure is not about hair, because facelift and brow lift incisions are hidden in or along a hairline that the disease can move, the temporal hair and sideburns that a facelift relies on are often the first casualties, and inflamed or thinned forehead skin changes how fillers, neurotoxin, and resurfacing behave.

Many FFA patients are in the same age group as facelift and brow lift patients, and the overlap creates planning problems that are easy to miss.

Incision placement. A facelift incision usually runs in or along the temporal hair, in front of or behind the sideburn, and around the ear, and a brow lift incision runs either behind the hairline or right at it. These placements assume the hairline will stay where it is. In FFA, the temporal hairline and sideburns are exactly the areas that recede. An incision hidden in the temple hair today can be exposed bare skin in three years. The usual facelift move of lifting the temporal skin also shifts the sideburn upward and backward; when the sideburn is already thin or gone, the result can look like the unnatural, high, bare temple that the piece on facelift revision and the secondary facelift describes. Surgeons can adapt by placing incisions along the existing hairline rather than within it, by limiting how much temporal skin is moved, or by choosing a technique that redistributes tension elsewhere, but only if they know the diagnosis.

Brow lifts. A receding hairline already makes the forehead taller, and a coronal or high endoscopic brow lift that raises the hairline further can make it taller still. A pretrichial (hairline) incision, which can shorten the forehead, assumes the hairline is a stable landmark, which in FFA it is not. The tradeoffs between approaches are explained in the piece on lateral brow lift versus forehead lift. The outer brow, the part a lateral brow lift aims to raise, is also where FFA brow loss tends to start. Lifting a brow that has lost much of its hair can emphasize the gap; a patient whose concern is really missing hair rather than a low brow may not need a lift at all, a distinction the piece on hooded eyes versus brow ptosis makes from another angle. Neurotoxin brow shaping, described in the piece on the chemical brow lift, may give a modest lift without incisions while the disease is being assessed.

Surgery as a trigger. Case reports have described scarring alopecia appearing along facelift and brow lift incisions and after hair transplants, sometimes in patients who had not been diagnosed before. Whether surgery triggers disease in susceptible people or simply reveals disease that was already beginning is unclear, and the reports are small. The practical lesson is that a patient with active FFA should have the disease addressed before elective surgery near the hairline, and that new hair loss along an incision after any facial operation deserves a dermatology look rather than reassurance that it is shock loss, the temporary shedding that the piece on hair dye and hair washing after a facelift touches on.

Fillers and resurfacing on the forehead and temples. The bare band in FFA is often thinner than the surrounding skin, and the forehead veins can become more visible. Patients sometimes seek filler for a flat forehead or hollow temples, the procedures covered in the piece on forehead filler and forehead augmentation and the piece on filler for hollow temples. Thin, scarred skin makes filler more visible and the vascular anatomy of the forehead and temple carries real risk in any patient, so injectors should know the diagnosis and favor conservative amounts. Lasers and peels aimed at sun damage on the forehead and temples deserve the same caution: inflamed skin heals less predictably, and in patients with lichen planus pigmentosus, heat-based treatments can deepen the brown-gray pigment. That is a theme shared with the piece on melasma treatment, where aggressive lasers can make pigment worse.

Steroids and healing. Patients receiving steroid injections at the hairline, or oral immune-modulating drugs, should tell the surgeon. Repeated injections thin the skin locally. Some oral drugs used in FFA affect healing or infection risk and may need to be paused around surgery, a decision for the prescribing dermatologist and the surgeon together. Finasteride and dutasteride generally do not interfere with wound healing, but they belong on the medication list.

Camouflage, skin care, pigment, and who should be on the team

The short answer: for most people with FFA, the most reliable cosmetic gains come from camouflage rather than surgery: hairstyling, fibers and toppers, scalp micropigmentation, and cosmetic eyebrow tattooing, done in quiet skin by practitioners who know the diagnosis, alongside dermatology care that keeps the disease controlled.

Hairstyling and hairpieces. A soft fringe or a side-swept style can cover a receded front edge with nothing more than a haircut, and a good stylist who knows about the condition is worth more than many devices. Hair fibers and tinted powders fill in thinning areas around the margin. Partial hairpieces, often called toppers, and full wigs have become far more natural looking over the past decade. These options are reversible, cost nothing in donor hair or forehead skin, and can be changed if the hairline moves.

Scalp micropigmentation. This is a cosmetic tattoo of tiny dots that mimic the look of hair follicles or soften the contrast between the bare band and the hairline. It suits people who wear their hair short or need to blend a thin area, and it is less convincing as a substitute for a full long-haired hairline. Tattooing into inflamed skin is generally discouraged, both because it can irritate the disease and because a moving hairline can leave the pigment stranded. The piece on scar camouflage and medical tattooing covers the principles of pigment work on altered skin.

Eyebrows. Microblading and powder brow tattooing can restore the look of a full brow when the follicles are gone. They are probably the most satisfying cosmetic intervention for many FFA patients. The pigment fades and needs touch-ups, the ink can shift in color over time, and a tattooed brow placed during active disease may sit in skin that becomes inflamed. Removal is harder than placement, as the piece on laser tattoo removal explains, so a conservative shape is safer than a bold one. Patients who have lost eyelashes as well should be cautious about lash growth serums, whose benefits and side effects are discussed in the piece on eyelash growth serums; they are not a treatment for scarring loss.

Skin care and sun protection. Because of the reported association with leave-on facial products, some dermatologists suggest that patients with FFA avoid applying facial creams and sunscreens onto the hairline itself, use simple products, or choose a hat or mineral-based option. Those are reasonable individual decisions to make with a doctor, not a reason to stop sun protection. Sun damage, actinic changes, and skin cancer remain real risks on a forehead that is suddenly bare.

Emotional weight and expectations. Losing a hairline and eyebrows changes the face in ways that many patients describe as aging overnight, and the uncertainty about whether it will keep going can be harder than the loss itself. Patient support groups, including the Cicatricial Alopecia Research Foundation, offer information and community. A patient who has become preoccupied with the hairline to the point that it dominates daily life deserves to have that addressed directly, and the piece on body dysmorphic disorder screening explains why that conversation belongs in any cosmetic consultation.

Who should be involved. The diagnosis and medical treatment belong to a dermatologist, ideally one with experience in hair disorders. Hair restoration surgery, if it is ever done, belongs to a surgeon who regularly treats scarring alopecias and is willing to coordinate with that dermatologist. Facelifts and brow lifts belong to surgeons certified by the American Board of Plastic Surgery or the American Board of Facial Plastic and Reconstructive Surgery, as described in the piece on board certifications, and those surgeons should be told about the diagnosis at the first visit. Cosmetic tattooing is largely regulated as tattooing rather than as medicine, so training and experience vary widely; asking whether the artist has worked with scarring alopecia is a fair question. And because transplants, revisions, and repeat tattoo sessions add up, the piece on what a surgical quote covers is worth reading before anyone signs up for a multi-stage plan.

The honest summary

A hairline that has moved and eyebrows that have thinned are not always ordinary aging. In postmenopausal women in particular, that combination is the classic sign of frontal fibrosing alopecia, a scarring form of hair loss in which the follicles are destroyed and the hair does not grow back. It is diagnosed by a dermatologist, often with dermoscopy and a biopsy, and treated with medications that aim to stop progression. None of those medications is approved specifically for the condition, and stability is something to document over time, not assume.

That changes the cosmetic plan. Hair transplants in FFA often look good for a year and then fade as the disease reaches the new grafts, and they spend donor hair that cannot be replaced. Hairline lowering advances skin whose hair may be next to go and places a scar on a hairline that may keep moving. Eyebrow transplants face the same problem. Facelift and brow lift incisions hidden in the temporal hair or along the hairline can become exposed, and the sideburns a facelift depends on are often already thin. Fillers, lasers, and peels on the forehead and temples need extra caution in thin or pigmented skin.

The practical sequence is clear. Get the diagnosis from a dermatologist before getting a quote from a surgeon. Treat the disease and measure it until it is quiet. Start with camouflage, which is reversible and does not spend anything that cannot be replaced: styling, fibers, toppers, micropigmentation, and cosmetic brows. Tell every surgeon and injector about the diagnosis at the first visit, and expect incision plans to change because of it. Patients who follow that order tend to end up with a face they recognize and options still available. Patients who skip straight to a transplant or a forehead reduction sometimes find, a few years later, that the disease has moved on and taken the result with it.